1797905-42-0 Usage
Description
C26H24FNO3, also known as Atorvastatin impurity A791750, is an organic compound that serves as an intermediate in the preparation of Atorvastatin, a widely used drug for treating high cholesterol and related cardiovascular conditions. It is characterized by its white solid appearance and contains a fluorine atom, which may contribute to its specific chemical properties and reactivity.
Uses
Used in Pharmaceutical Industry:
C26H24FNO3 is used as an intermediate in the synthesis of Atorvastatin for the treatment of high cholesterol and related cardiovascular diseases. Its role in the production process is crucial for the development of this widely prescribed medication.
Used in Chemical Research:
As an organic compound with a unique structure, C26H24FNO3 can be used in various chemical research applications to study its properties, reactivity, and potential for further drug development or other industrial uses.
Used in Quality Control and Impurity Profiling:
In the pharmaceutical industry, C26H24FNO3 is used for quality control purposes to ensure the purity and safety of Atorvastatin products. It helps in the identification and quantification of impurities, which is essential for maintaining the drug's efficacy and safety profile.
Used in Drug Development:
The unique structure and properties of C26H24FNO3 may also make it a valuable compound for drug development research. Scientists can explore its potential for creating new drugs or modifying existing ones to improve their effectiveness or reduce side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 1797905-42-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,7,9,7,9,0 and 5 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1797905-42:
(9*1)+(8*7)+(7*9)+(6*7)+(5*9)+(4*0)+(3*5)+(2*4)+(1*2)=240
240 % 10 = 0
So 1797905-42-0 is a valid CAS Registry Number.
1797905-42-0Relevant articles and documents
Preparation method of atorvastatin calcium isomers
-
, (2018/09/11)
The invention relates to a preparation method of atorvastatin calcium isomers [R-(R*,R*)]-2-(3-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-2-phenyl-4-[(aniline)carbonyl]-1H-pyrrole-1-calciumenanthate salt (IMP-1 for short) and [R-(R*,R*)]-3-(2-fluorophenyl)-beta, delta-dihydroxyl -5-(1-Methylethyl)-3-phenyl-4-[(anilino)carbonyl]-1H-pyrrole-1- calcium enanthate salt (IMP-2 for short). According to the preparation method, a preparation method of a reference substance is provided for the quality research of drugs, and an important guiding significance is provided for the safe medicationof atorvastatin calcium.
